Log in to save to my catalogue

PP45 The Cost-Of-Illness Of Diabetic Macular Edema In Italy

PP45 The Cost-Of-Illness Of Diabetic Macular Edema In Italy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11738291

PP45 The Cost-Of-Illness Of Diabetic Macular Edema In Italy

About this item

Full title

PP45 The Cost-Of-Illness Of Diabetic Macular Edema In Italy

Publisher

New York, USA: Cambridge University Press

Journal title

International journal of technology assessment in health care, 2022-12, Vol.38 (S1), p.S55-S55

Language

English

Formats

Publication information

Publisher

New York, USA: Cambridge University Press

More information

Scope and Contents

Contents

IntroductionDiabetic Macular Edema (DME) is an important complication of Diabetic Retinopathy (DR). Intravitreal steroids in slow-release systems represent a safe and effective therapeutic option for the management of DME, capable of improving patients’ quality of life by reducing the number of injections thus increasing the therapeutic adherence a...

Alternative Titles

Full title

PP45 The Cost-Of-Illness Of Diabetic Macular Edema In Italy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11738291

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11738291

Other Identifiers

ISSN

0266-4623

E-ISSN

1471-6348

DOI

10.1017/S0266462322001854

How to access this item